Form 4: Zimmer Biomet Executive Wilfred van Zuilen Reports Stock Transactions
SEC Form 4 Filing
Wilfred van Zuilen, Group President EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On July 1, 2024, Wilfred van Zuilen, Group President EMEA of Zimmer Biomet Holdings, Inc., had 2,633 restricted stock units (RSUs) vest.
- Following the vesting, 557 shares were withheld by the company to cover tax obligations at a price of $107.36 per share.
- Van Zuilen now directly owns 9,243 shares of Zimmer Biomet common stock.
- He also holds 2,631 unvested RSUs, scheduled to vest on July 1, 2025.
Sentiment
Score: 5
Explanation: This is a neutral report on insider transactions, reflecting standard compensation practices. It doesn't inherently indicate positive or negative sentiment.
Future Outlook
The remaining 2,631 RSUs are scheduled to vest on July 1, 2025.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the stock ownership of Zimmer Biomet's executives. It's common for executives to receive stock-based compensation, and these filings are a regular occurrence.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Vesting of 2,633 restricted stock units and tax withholding. |
| 07/01/2025 | Scheduled vesting date for the remaining 2,631 restricted stock units. |
| 07/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.